X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare SUVEN LIFE with Orchid Chemicals - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SUVEN LIFE vs ORCHID PHARMA LTD - Comparison Results

ORCHID PHARMA LTD 
   Change

Orchid Chemicals & Pharmaceuticals Ltd. (Orchid) is today a globally recognized, integrated pharmaceutical company with core competencies in the development and manufacture of Active Pharmaceutical Ingredients (APIs) and Finished Dosage Forms as well... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SUVEN LIFE ORCHID PHARMA LTD SUVEN LIFE/
ORCHID PHARMA LTD
 
P/E (TTM) x 16.3 -0.8 - View Chart
P/BV x 3.0 0.6 541.9% View Chart
Dividend Yield % 1.2 0.0 -  

Financials

 SUVEN LIFE   ORCHID PHARMA LTD
EQUITY SHARE DATA
    SUVEN LIFE
Mar-16
ORCHID PHARMA LTD
Sep-13
SUVEN LIFE/
ORCHID PHARMA LTD
5-Yr Chart
Click to enlarge
High Rs339194 174.5%   
Low Rs14435 412.6%   
Sales per share (Unadj.) Rs39.2276.5 14.2%  
Earnings per share (Unadj.) Rs7.5-79.2 -9.4%  
Cash flow per share (Unadj.) Rs8.8-43.5 -20.2%  
Dividends per share (Unadj.) Rs2.000-  
Dividend yield (eoy) %0.80-  
Book value per share (Unadj.) Rs49.053.9 90.8%  
Shares outstanding (eoy) m127.2870.45 180.7%   
Bonus/Rights/Conversions -ESOP-  
Price / Sales ratio x6.20.4 1,485.5%   
Avg P/E ratio x32.4-1.4 -2,238.6%  
P/CF ratio (eoy) x27.5-2.6 -1,044.2%  
Price / Book Value ratio x4.92.1 232.1%  
Dividend payout %26.80-   
Avg Mkt Cap Rs m30,7328,067 381.0%   
No. of employees `0001.02.8 34.1%   
Total wages/salary Rs m4162,527 16.5%   
Avg. sales/employee Rs Th5,236.16,956.1 75.3%   
Avg. wages/employee Rs Th436.5902.5 48.4%   
Avg. net profit/employee Rs Th995.5-1,993.0 -50.0%   
INCOME DATA
Net Sales Rs m4,99519,477 25.6%  
Other income Rs m194407 47.5%   
Total revenues Rs m5,18919,884 26.1%   
Gross profit Rs m1,2331,103 111.8%  
Depreciation Rs m1672,519 6.6%   
Interest Rs m545,227 1.0%   
Profit before tax Rs m1,205-6,236 -19.3%   
Minority Interest Rs m020 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0511 0.0%   
Tax Rs m255-125 -203.7%   
Profit after tax Rs m950-5,580 -17.0%  
Gross profit margin %24.75.7 435.9%  
Effective tax rate %21.22.0 1,054.3%   
Net profit margin %19.0-28.7 -66.4%  
BALANCE SHEET DATA
Current assets Rs m4,98611,014 45.3%   
Current liabilities Rs m1,04232,060 3.3%   
Net working cap to sales %79.0-108.1 -73.1%  
Current ratio x4.80.3 1,392.5%  
Inventory Days Days6195 64.3%  
Debtors Days Days3934 116.6%  
Net fixed assets Rs m3,12629,440 10.6%   
Share capital Rs m127705 18.1%   
"Free" reserves Rs m3,7172,043 182.0%   
Net worth Rs m6,2363,800 164.1%   
Long term debt Rs m4329,018 4.8%   
Total assets Rs m8,07946,510 17.4%  
Interest coverage x23.2-0.2 -12,027.2%   
Debt to equity ratio x0.12.4 2.9%  
Sales to assets ratio x0.60.4 147.6%   
Return on assets %12.4-0.8 -1,634.9%  
Return on equity %15.2-146.9 -10.4%  
Return on capital %18.9-3.7 -505.5%  
Exports to sales %87.537.9 231.0%   
Imports to sales %12.222.6 54.1%   
Exports (fob) Rs m4,3717,378 59.2%   
Imports (cif) Rs m6114,406 13.9%   
Fx inflow Rs m4,6667,513 62.1%   
Fx outflow Rs m9425,649 16.7%   
Net fx Rs m3,7241,865 199.8%   
CASH FLOW
From Operations Rs m9221,682 54.8%  
From Investments Rs m-619-9,860 6.3%  
From Financial Activity Rs m-6986,644 -10.5%  
Net Cashflow Rs m-396-1,535 25.8%  

Share Holding

Indian Promoters % 63.4 32.3 196.3%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.0 4.6 -  
FIIs % 0.0 3.3 -  
ADR/GDR % 0.0 4.6 -  
Free float % 36.5 55.3 66.0%  
Shareholders   37,287 84,811 44.0%  
Pledged promoter(s) holding % 0.0 54.9 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SUVEN LIFE With:   DR. REDDYS LAB  IPCA LABS  ASTRAZENECA PHARMA  VENUS REMEDIES  PIRAMAL ENTERPRISES  

Compare SUVEN LIFE With:   ACTAVIS (US)  MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Opens Flat; Infosys Down 4.1%(09:30 am)

Asian stock markets opened mixed in early trade today. Hong Kong Hang Seng has advanced 143 points and China's Shanghai Composite has gained 9 points.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

A 'Backdoor' to Multibaggers: It's Like Investing in Asian Paints Ten Years Ago(The 5 Minute Wrapup)

Aug 10, 2017

Don't miss these proxy bets on growing companies or in a few years you will be looking back with regret.

The Most Profitable Investment in the History of the World(Vivek Kaul's Diary)

Aug 8, 2017

'Yes, it looks like a bubble. And, yes, it's like buying a lottery ticket. But there's something happening that has never happened before. It's an evolutionary leap in money itself.'

Should You Invest In Bharat-22 ETF? Know Here...(Outside View)

Aug 8, 2017

Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

Bitcoin Continues Stellar Rise(Chart Of The Day)

Aug 10, 2017

Bitcoin hits an all-time high, is there more upside left?

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

SUVEN LIFE SHARE PRICE


Aug 21, 2017 10:57 AM

TRACK SUVEN LIFE

  • Track your investment in SUVEN LIFE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

COMPARE SUVEN LIFE WITH

MARKET STATS